Combining immunomodulators and antivirals for COVID-19 – Authors' reply

Raquel Almansa; Ana P. Tedim; Amanda de la Fuente; Jose María Eiros; David J. Kelvin; Antoni Torres; Jesus F. Bermejo-Martin

doi:10.1016/S2666-5247(21)00115-4

Combining immunomodulators and antivirals for COVID-19 – Authors' reply

Raquel Almansa, Ana P. Tedim, Amanda de la Fuente, Jose María Eiros, David J. Kelvin, Antoni Torres, Jesus F. Bermejo-Martin

Medicine

Medicine

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	e234
Journal	The Lancet Microbe
Volume	2
Issue number	6
DOIs	https://doi.org/10.1016/S2666-5247(21)00115-4
Publication status	Published - Jun 2021

Bibliographical note

Funding Information:
JFB-M, RA, APT, JME, AT, and DJK have a patent pending (EP20383140.9). AT reports grants from Instituto de Salud Carlos III. DJK reports grants from Canadian Institutes of Health Research, Research Nova Scotia, Atlantic Genome/Genome Canada, Li-Ka Shing Foundation, and Dalhousie Medical Research Foundation. AdlF declares no competing interests.

ASJC Scopus Subject Areas

Infectious Diseases
Microbiology (medical)
Microbiology
Virology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S2666-5247(21)00115-4

Cite this

@article{68fd2e232aa94eb08731088da3f57331,

title = "Combining immunomodulators and antivirals for COVID-19 – Authors' reply",

author = "Raquel Almansa and Tedim, {Ana P.} and {de la Fuente}, Amanda and Eiros, {Jose Mar{\'i}a} and Kelvin, {David J.} and Antoni Torres and Bermejo-Martin, {Jesus F.}",

note = "Funding Information: JFB-M, RA, APT, JME, AT, and DJK have a patent pending (EP20383140.9). AT reports grants from Instituto de Salud Carlos III. DJK reports grants from Canadian Institutes of Health Research, Research Nova Scotia, Atlantic Genome/Genome Canada, Li-Ka Shing Foundation, and Dalhousie Medical Research Foundation. AdlF declares no competing interests.",

year = "2021",

month = jun,

doi = "10.1016/S2666-5247(21)00115-4",

language = "English",

volume = "2",

pages = "e234",

journal = "The Lancet Microbe",

issn = "2666-5247",

publisher = "Elsevier Ltd.",

number = "6",

}

TY - JOUR

T1 - Combining immunomodulators and antivirals for COVID-19 – Authors' reply

AU - Almansa, Raquel

AU - Tedim, Ana P.

AU - de la Fuente, Amanda

AU - Eiros, Jose María

AU - Kelvin, David J.

AU - Torres, Antoni

AU - Bermejo-Martin, Jesus F.

N1 - Funding Information: JFB-M, RA, APT, JME, AT, and DJK have a patent pending (EP20383140.9). AT reports grants from Instituto de Salud Carlos III. DJK reports grants from Canadian Institutes of Health Research, Research Nova Scotia, Atlantic Genome/Genome Canada, Li-Ka Shing Foundation, and Dalhousie Medical Research Foundation. AdlF declares no competing interests.

PY - 2021/6

Y1 - 2021/6

UR - http://www.scopus.com/inward/record.url?scp=85107112347&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85107112347&partnerID=8YFLogxK

U2 - 10.1016/S2666-5247(21)00115-4

DO - 10.1016/S2666-5247(21)00115-4

M3 - Letter

AN - SCOPUS:85107112347

SN - 2666-5247

VL - 2

SP - e234

JO - The Lancet Microbe

JF - The Lancet Microbe

IS - 6

ER -

Combining immunomodulators and antivirals for COVID-19 – Authors' reply

Bibliographical note

ASJC Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Cite this